ATP1A3 and Dystonia: In a study by Panagiotakaki et al., there was no significant difference in the frequency and duration of onset of hemiplegia, dystonia, and abnormal eye movement and the severity of mental and motor disorders between ATP1A3 mutation-negative and -positive patients (12).